Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

7.87
+0.39005.21%
Post-market: 7.870.00000.00%16:10 EST
Volume:130.48K
Turnover:1.01M
Market Cap:204.65M
PE:-4.20
High:8.02
Open:7.50
Low:7.39
Close:7.48
52wk High:18.80
52wk Low:5.98
Shares:26.00M
Float Shares:9.39M
Volume Ratio:0.81
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8750
EPS(LYR):-4.4814
ROE:-7029.26%
ROA:-12.67%
PB:-5.71
PE(LYR):-1.76

Loading ...

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Cartesian Therapeutics (RNAC) and Anixa Biosciences (ANIX)

TIPRANKS
·
Nov 07, 2025

Needham Sticks to Their Buy Rating for Cartesian Therapeutics (RNAC)

TIPRANKS
·
Nov 07, 2025

Cartesian Therapeutics Q3 EPS $(1.38) Misses $(0.84) Estimate, Sales $452.000K Beat $243.500K Estimate

Benzinga
·
Nov 06, 2025

Cartesian Therapeutics reports Q3 EPS ($1.38) vs ($1.13) last year

TIPRANKS
·
Nov 06, 2025

Cartesian Therapeutics About $145.1 Mln Cash, Cash Equivalents & Restricted Cash at Sept 30, Expected to Support Planned Operations Into Mid-2027

THOMSON REUTERS
·
Nov 06, 2025

Cartesian Therapeutics Inc expected to post a loss of 84 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire
·
Oct 30, 2025

Cartesian Therapeutics Inc - Carrie S. Cox Steps Down as Chairman

THOMSON REUTERS
·
Oct 30, 2025

Press Release: Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company's Board of Directors

Dow Jones
·
Oct 30, 2025

Cartesian Therapeutics Files Initial Beneficial Ownership Statement for Chief Accounting Officer June Ann Seymour

Reuters
·
Oct 29, 2025

Cartesian Therapeutics Advances Autoimmune Disorder Treatment with Descartes-08 Study

TIPRANKS
·
Oct 28, 2025

Cartesian Therapeutics: Delivered Notice of Termination of Employment Without Cause to Christopher Jewell, Current Chief Scientific Officer

THOMSON REUTERS
·
Oct 21, 2025

Cartesian Therapeutics Inc -on Oct 15, Eliminates Chief Scientific Officer Position - SEC Filing

THOMSON REUTERS
·
Oct 21, 2025

Cartesian Therapeutics Eliminates Chief Scientific Officer Position

Reuters
·
Oct 21, 2025

Cartesian Therapeutics appoints June Seymour as Chief Accounting Officer

Reuters
·
Oct 08, 2025

Cartesian Therapeutics announces employment inducement grant

TIPRANKS
·
Oct 03, 2025

Cartesian Therapeutics Announces New Employment Inducement Grant

GlobeNewswire
·
Oct 03, 2025